阿尔茨海默病:组合疗法和临床试验的组合疗法开发
Jeffrey L Cummings1,2,3, Amanda M Leisgang Osse4,5, Jefferson W Kinney4,5
1Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV, Las Vegas, NV, USA. jcummings@cnsinnovations.com.
CNS drugs
|June 27, 2024
概括
组合疗法对于阿尔茨海默病 (AD) 治疗至关重要,可能将新药与现有的抗粉样蛋白单克隆抗体结合起来,以减缓认知衰退. 需要进一步的研究来优化这些组合策略,以获得更大的患者益处.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 阿尔茨海默病 (AD) 是一种复杂的神经系统疾病.
- 目前的抗粉样蛋白单克隆抗体可以适度减缓疾病的进展 (大约1. 只有30%).
- 组合疗法可能是必要的,以更有效地预防AD发病或减缓认知衰退.
研究的目的:
- 探索阿尔茨海默病综合疗法的必要性和策略.
- 概述共同开发和添加组合疗法的开发途径.
- 为了解决联合治疗研究的迫切需要,特别是对于正在接受现有抗粉样蛋白治疗的患者.
主要方法:
- 对潜在的组合治疗方法的审查 (联合开发与附加).
- 考虑对附加疗法的临床试验设计 (第一,第二,第三阶段).
- 在组合试验和基于网络的医学中强调生物标志物分析,以确定合理的组合.
主要成果:
- 组合疗法可以针对AD的核心病理,共同病理 (例如炎症) 或同时发生的非AD病理 (例如α-synuclein).
- 添加组合策略对于目前接受抗粉样蛋白单克隆抗体的患者至关重要.
- 在组合试验中,必须仔细评估生物标志物变化,以了解药物效应.
结论:
- 组合疗法是推动阿尔茨海默病治疗的关键下一步.
- 战略开发,包括强大的临床试验设计和生物标志物分析,对于成功实施组合疗法至关重要.
- 计算方法可以帮助识别AD的最佳药物组合.
更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
7.9K
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
42.3K
相关概念视频
01:22Alzheimer's Disease: Treatment
178
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
178
01:26Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:16Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
118
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
118
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41